Skip to main content
Premium Trial:

Request an Annual Quote

Actar to Use Corning's Epic System in Screening Services

NEW YORK (GenomeWeb News) – Actar, a part of the Karolinska Institutet innovations system in Sweden, has purchased Corning’s Epic System, which it will use in providing label-free drug screening services.
 
According to Corning, Actar is the first and only company to offer high-throughput, label-free drug screening to academic researchers in Scandanavia and Europe on a fee-for-service basis.
 
The Epic system uses optical biosensors to measure a broad range of biological responses that are undetectable with conventional methods, said Corning. The firm claims it is the world’s first high-throughput, label-free screening system.
 
Financial terms of the purchase were not disclosed.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.